Regulation of ERRα gene expression by estrogen receptor agonists and antagonists in SKBR3 breast cancer cells: Differential molecular mechanisms mediated by G protein-coupled receptor GPR30/GPER-1

Molecular Endocrinology

Volumn 24, Issue 5, 2010, Pages 969-980

  Li, Yin ^a   Birnbaumer, Lutz ^a   Teng, Christina T ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RELATED RECEPTOR ALPHA; FULVESTRANT; G PROTEIN COUPLED RECEPTOR; MESSENGER RNA; SMALL INTERFERING RNA; TAMOXIFEN; 1 (4 (6 BROMOBENZO(1,3)DIOXOL 5 YL) 3A,4,5,9B TETRAHYDRO 3H CYCLOPENTA(C)QUINOLIN 8 YL)ETHANONE; 1-(4-(6-BROMOBENZO(1,3)DIOXOL-5-YL)-3A,4,5,9B-TETRAHYDRO-3H-CYCLOPENTA(C)QUINOLIN-8-YL)ETHANONE; CYCLOPENTANE DERIVATIVE; DRUG DERIVATIVE; ERRALPHA ESTROGEN RELATED RECEPTOR; ERRALPHA ESTROGEN-RELATED RECEPTOR; ESTROGEN RECEPTOR; GPER PROTEIN, HUMAN; HISTONE; QUINOLINE DERIVATIVE;

ARTICLE; BREAST CANCER; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; ESTROGEN ACTIVITY; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; NUCLEOSOME; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TRANSCRIPTION REGULATION; ACETYLATION; BREAST TUMOR; CHROMATIN IMMUNOPRECIPITATION; DRUG ANTAGONISM; DRUG POTENTIATION; GENE EXPRESSION; GENETICS; METABOLISM; PHYSIOLOGY; POLYMERASE CHAIN REACTION; PROMOTER REGION; PROTEIN TRANSPORT; RNA INTERFERENCE; TUMOR CELL LINE; WESTERN BLOTTING;

ACETYLATION; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; CYCLOPENTANES; ESTRADIOL; GENE EXPRESSION; HISTONES; HUMANS; POLYMERASE CHAIN REACTION; PROMOTER REGIONS, GENETIC; PROTEIN TRANSPORT; QUINOLINES; RECEPTORS, ESTROGEN; RECEPTORS, G-PROTEIN-COUPLED; RNA INTERFERENCE; TAMOXIFEN;

EID: 77954835756     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2009-0148     Document Type: Article

References (63)

1. Deroo BJ, Korach KS 2006 Estrogen receptors and human disease. J Clin Invest 116:561-570
2. Yager JD, Davidson NE 2006 Estrogen carcinogenesis in breast cancer. N Engl J Med 354:270-282
3. Matthews J, Gustafsson JA 2003 Estrogen signaling: a subtle balance between ERα and ERβ. Mol Interv 3:281-292
4. Klinge CM, Jernigan SC, Mattingly KA, Risinger KE, Zhang J 2004 Estrogen response element-dependent regulation of transcriptional activation of estrogen receptors α and β by coactivators and corepressors. J Mol Endocrinol 33:387-410
5. Safe S 2001 Transcriptional activation of genes by 17β-estradiol through estrogen receptor-Sp1 interactions. Vitam Horm 62:231-252
6. Umayahara Y, Kawamori R, Watada H, Imano E, Iwama N, Morishima T, Yamasaki Y, Kajimoto Y, Kamada T 1994 Estrogen regulation of the insulin-like growth factor I gene transcription involves an AP-1 enhancer. J Biol Chem 269:16433-16442
7. Hu P, Kinyamu HK, Wang L, Martin J, Archer TK, Teng C 2008 Estrogen induces estrogen-related receptor α gene expression and chromatin structural changes in estrogen receptor (ER)-positive and ER-negative breast cancer cells. J Biol Chem 283:6752-6763
8. Björnström L, Sjöberg M 2005 Mechanisms of estrogen receptor signaling: convergence of genomic and nongenomic actions on target genes. Mol Endocrinol 19:833-842
9. Levin ER 2005 Integration of the extranuclear and nuclear actions of estrogen. Mol Endocrinol 19:1951-1959
10. Vasudevan N, Pfaff DW 2007 Membrane-initiated actions of estrogens in neuroendocrinology: emerging principles. Endocr Rev 28:1-19
11. Filardo EJ, Quinn JA, Frackelton Jr AR, Bland KI 2002 Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis. Mol Endocrinol 16:70-84
12. Filardo EJ, Thomas P 2005 GPR30: a seven-transmembrane-spanning estrogen receptor that triggers EGF release. Trends Endocrinol Metab 16:362-367 (Pubitemid 41338741)
13. Revankar CM, Cimino DF, Sklar LA, Arterburn JB, Prossnitz ER 2005 A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 307:1625-1630
14. Thomas P, Pang Y, Filardo EJ, Dong J 2005 Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology 146:624-632
15. Bologa CG, Revankar CM, Young SM, Edwards BS, Arterburn JB, Kiselyov AS, Parker MA, Tkachenko SE, Savchuck NP, Sklar LA, Oprea TI, Prossnitz ER 2006 Virtual and biomolecular screening converge on a selective agonist for GPR30. Nat Chem Biol 2:207-212
16. Kroeze WK, Sheffler DJ, Roth BL 2003 G-protein-coupled receptors at a glance. J Cell Sci 116:4867-4869
17. Maggiolini M, Vivacqua A, Fasanella G, Recchia AG, Sisci D, Pezzi V, Montanaro D, Musti AM, Picard D, Andò S 2004 The G protein-coupled receptor GPR30 mediates c-fos up-regulation by 17β-estradiol and phytoestrogens in breast cancer cells. J Biol Chem 279:27008-27016
18. Committee NRN 1999 A unified nomenclature system for the nuclear receptor superfamily. Cell 97:161-163
19. Giguère V, Yang N, Segui P, Evans RM 1988 Identification of a new class of steroid hormone receptors. Nature 331:91-94
20. Villena JA, Kralli A 2008 ERRα: a metabolic function for the oldest orphan. Trends Endocrinol Metab 19:269-276
21. Mootha VK, Handschin C, Arlow D, Xie X, St Pierre J, Sihag S, Yang W, Altshuler D, Puigserver P, Patterson N, Willy PJ, Schulman IG, Heyman RA, Lander ES, Spiegelman BM 2004 Errα and Gabpa/b specify PGC-1α-dependent oxidative phosphorylation gene expression that is altered in diabetic muscle. Proc Natl Acad Sci USA 101:6570-6575
22. Wang L, Li Y, Hu P, Teng CT 2008 PGC-1α induces dynamic protein interactions on the ERRα gene multi-hormone response element nucleosome in kidney cells. Biochem J 416:407-419
23. Knutti D, Kralli A 2001 PGC-1, a versatile coactivator. Trends Endocrinol Metab 12:360-365
24. Puigserver P, Spiegelman BM 2003 Peroxisome proliferator-activated receptor-γ coactivator 1α (PGC-1α): transcriptional coactivator and metabolic regulator. Endocr Rev 24:78-90 (Pubitemid 36223280)
25. Kallen J, Schlaeppi JM, Bitsch F, Filipuzzi I, Schilb A, Riou V, Graham A, Strauss A, Geiser M, Fournier B 2004 Evidence for ligand-independent transcriptional activation of the human estrogen- related receptor α (ERRα): crystal structure of ERRα ligand binding domain in complex with peroxisome proliferator-activated receptor coactivator-1α. J Biol Chem 279:49330-49337
26. Zhang Z, Teng CT 2000 Estrogen receptor-related receptor α 1 interacts with coactivator and constitutively activates the estrogen response elements of the human lactoferrin gene. J Biol Chem 275: 20837-20846
27. Liu D, Zhang Z, Gladwell W, Teng CT 2003 Estrogen stimulates estrogen-related receptor α gene expression through conserved hormone response elements. Endocrinology 144:4894-4904
28. Shigeta H, Zuo W, Yang N, DiAugustine R, Teng CT 1997 The mouse estrogen receptor-related orphan receptor α1: molecular cloning and estrogen responsiveness. J Mol Endocrinol 19:299-309
29. Liu D, Benlhabib H, Mendelson CR 2009 cAMP Enhances estrogen-related receptor α (ERRα) transcriptional activity at the SP-A promoter by increasing its interaction with protein kinase A and steroid receptor coactivator 2 (SRC-2). Mol Endocrinol 23:772-783
30. Barry JB, Laganière J, Giguère V 2006 A single nucleotide in an estrogen-related receptor a site can dictate mode of binding and peroxisome proliferator-activated receptor G coactivator 1a activation of target promoters. Mol Endocrinol 20:302-310
31. Johnston SD, Liu X, Zuo F, Eisenbraun TL, Wiley SR, Kraus RJ, Mertz JE 1997 Estrogen-related receptor α1 functionally binds as a monomer to extended half-site sequences including ones contained within estrogen-response elements. Mol Endocrinol 11:342-352
32. Yang N, Shigeta H, Shi H, Teng CT 1996 Estrogen-related receptor, hERR1, modulates estrogen receptor-mediated response of human lactoferrin gene promoter. J Biol Chem 271:5795-5804
33. Vanacker JM, Pettersson K, Gustafsson JA, Laudet V 1999 Transcriptional targets shared by estrogen receptor-related receptors (ERRs) and estrogen receptor (ER)α, but not by ERβ. EMBO J 18:4270-4279
34. Laganière J, Tremblay GB, Dufour CR, Giroux S, Rousseau F, Giguère V 2004 A polymorphic autoregulatory hormone response element in the human estrogen-related receptor α (ERRα) promoter dictates peroxisome proliferator-activated receptor γ coactivator-1α control of ERRα expression. J Biol Chem 279:18504-18510
35. Zhang Z, Chen K, Shih JC, Teng CT 2006 Estrogen-related receptors-stimulated monoamine oxidase B promoter activity is downregulated by estrogen receptors. Mol Endocrinol 20:1547-1561
36. Ariazi EA, Clark GM, Mertz JE 2002 Estrogen-related receptor α and estrogen-related receptor γ associate with unfavorable and favorable biomarkers, respectively, in human breast cancer. Cancer Res 62:6510-6518
37. Suzuki T, Miki Y, Moriya T, Shimada N, Ishida T, Hirakawa H, Ohuchi N, Sasano H 2004 Estrogen-related receptor α in human breast carcinoma as a potent prognostic factor. Can Res 64:4670-4676 (Pubitemid 38856942)
38. Stein RA, Chang CY, Kazmin DA, Way J, Schroeder T, Wergin M, Dewhirst MW, McDonnell DP 2008 Estrogen-related receptor α is critical for the growth of estrogen receptor-negative breast cancer. Cancer Res 68:8805-8812
39. Hynes NE, Stern DF 1994 The biology of erbB-2/neu/HER-2 and its role in cancer. Biochim Biophys Acta 1198:165-184
40. Chen S, Zhou D, Okubo T, Kao YC, Yang C 1999 Breast tumor aromatase: functional role and transcriptional regulation. Endocr Relat Cancer 6:149-156
41. Seely J, Amigh KS, Suzuki T, Mayhew B, Sasano H, Giguere V, Laganière J, Carr BR, Rainey WE 2005 Transcriptional regulation of dehydroepiandrosterone sulfotransferase (SULT2A1) by estrogen-related receptor α (ERRα). Endocrinology 146:3605-3613
42. Maggiolini M, Picard D 2010 The unfolding stories of GPR30, a new membrane-bound estrogen receptor. J Endocrinol 204:105-114
43. Prossnitz ER, Barton M 2009 Signaling, physiological functions and clinical relevance of the G protein-coupled estrogen receptor GPER. Prostaglandins Other Lipid Mediat 89:89-97
44. Prossnitz ER, Maggiolini M 2009 Mechanisms of estrogen signaling and gene expression via GPR30. Mol Cell Endocrinol 308:32-38
45. Vivacqua A, Bonofiglio D, Recchia AG, Musti AM, Picard D, Andò S, Maggiolini M 2006 The G protein-coupled receptor GPR30 mediates the proliferative effects induced by 17β-estradiol and hydroxytamoxifen in endometrial cancer cells. Mol Endocrinol 20: 631-646
46. Luttrell LM, Hawes BE, van Biesen T, Luttrell DK, Lansing TJ, Lefkowitz RJ 1996 Role of c-Src tyrosine kinase in G protein-coupled receptor- and Gβγ subunit-mediated activation of mitogen-activated protein kinases. J Biol Chem 271:19443-19450
47. Birnbaumer L 2007 Expansion of signal transduction by G proteins. The second 15 years or so: from 3 to 16 α subunits plus βγ dimers. Biochim Biophys Acta 1768:772-793
48. Sunahara RK, Dessauer CW, Gilman AG 1996 Complexity and diversity of mammalian adenylyl cyclases. Annu Rev Pharmacol Toxicol 36:461-480
49. Kouzarides T 2007 Chromatin modifications and their function. Cell 128:693-705
50. Li B, Carey M, Workman JL 2007 The role of chromatin during transcription. Cell 128:707-719
51. Shi H, Shigeta H, Yang N, Fu K, O'Brian G, Teng CT 1997 Human estrogen receptor-like 1 (ESRL1) gene: genomic organization, chromosomal localization, and promoter characterization. Genomics 44:52-60
52. Prenzel N, Zwick E, Leserer M, Ullrich A 2000 Tyrosine kinase signalling in breast cancer. Epidermal growth factor receptor: convergence point for signal integration and diversification. Breast Cancer Res 2:184-190
53. Levin ER 2003 Bidirectional signaling between the estrogen receptor and the epidermal growth factor receptor. Mol Endocrinol 17: 309-317
54. Shenoy SK, Drake MT, Nelson CD, Houtz DA, Xiao K, Madabushi S, Reiter E, Premont RT, Lichtarge O, Lefkowitz RJ 2006 β-Arrestin-dependent, G protein-independent ERK1/2 activation by the β2 adrenergic receptor. J Biol Chem 281:1261-1273
55. Deblois G, Hall JA, Perry MC, Laganière J, Ghahremani M, Park M, Hallett M, Giguère V 2009 Genome-wide identification of direct target genes implicates estrogen-related receptor α as a determinant of breast cancer heterogeneity. Cancer Res 69:6149-6157
56. Stein RA, McDonnell DP 2006 Estrogen-related receptor α as a therapeutic target in cancer. Endocr-Relat Cancer 13(Suppl 1):S25-S32
57. Cavallini A, Notarnicola M, Giannini R, Montemurro S, Lorusso D, Visconti A, Minervini F, Caruso MG 2005 Oestrogen receptor-related receptor α (ERRα) and oestrogen receptors (ERα and ERβ) exhibit different gene expression in human colorectal tumour progression. Eur J Cancer 41:1487-1494
58. Fujimura T, Takahashi S, Urano T, Kumagai J, Ogushi T, Horie-Inoue K, Ouchi Y, Kitamura T, Muramatsu M, Inoue S 2007 Increased expression of estrogen-related receptor α (ERRα) is a negative prognostic predictor in human prostate cancer. Int J Cancer 120:2325-2330
59. Yang C, Zhou D, Chen S 1998 Modulation of aromatase expression in the breast tissue by ERRα-1 orphan receptor. Cancer Res 58:5695-5700 (Pubitemid 29006408)
60. Miki Y, Suzuki T, Tazawa C, Yamaguchi Y, Kitada K, Honma S, Moriya T, Hirakawa H, Evans DB, Hayashi S, Ohuchi N, Sasano H 2007 Aromatase localization in human breast cancer tissues: possible interactions between intratumoral stromal and parenchymal cells. Cancer Res 67:3945-3954
61. Group EBCTC 2005 Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365:1687-1717
62. Hurtado A, Holmes KA, Geistlinger TR, Hutcheson IR, Nicholson RI, Brown M, Jiang J, Howat WJ, Ali S, Carroll JS 2008 Regulation of ERBB2 by oestrogen receptor-PAX2 determines response to tamoxifen. Nature 456:663-666
63. Lin BC, Suzawa M, Blind RD, Tobias SC, Bulun SE, Scanlan TS, Ingraham HA 2009 Stimulating the GPR30 estrogen receptor with a novel tamoxifen analogue activates SF-1 and promotes endometrial cell proliferation. Cancer Res 69:5415-5423